selected publications
- Immune-deficient bacteria serve as gateways to genetic exchange and microbial evolution. Nature communications. 2026 Academic Article GET IT
- Non-conjugative plasmids limit their mobility to persist in nature. Cell reports. 2025 Academic Article GET IT
-
Integrated Analysis of Patient Networks and Plasmid Genomes to Investigate a Regional, Multispecies Outbreak of Carbapenemase-Producing Enterobacterales Carrying Both blaIMP and mcr-9 Genes.
The Journal of infectious diseases.
2024
Academic Article
GET IT
Times cited: 9 - Antimicrobial peptide glatiramer acetate targets Pseudomonas aeruginosa lipopolysaccharides to breach membranes without altering lipopolysaccharide modification. npj antimicrobials and resistance. 2024 Academic Article GET IT
-
Lipopolysaccharide as an antibiotic target.
Biochimica et biophysica acta. Molecular cell research.
2023
Review
GET IT
Times cited: 37 -
Synergistic Activity of Repurposed Peptide Drug Glatiramer Acetate with Tobramycin against Cystic Fibrosis Pseudomonas aeruginosa.
Microbiology spectrum.
2022
Academic Article
GET IT
Times cited: 7 -
Polymyxin and lipopeptide antibiotics: membrane-targeting drugs of last resort.
Microbiology (Reading, England).
2022
Review
GET IT
Times cited: 96 -
Colistin resistance in Escherichia coli confers protection of the cytoplasmic but not outer membrane from the polymyxin antibiotic.
Microbiology (Reading, England).
2021
Academic Article
GET IT
Times cited: 34 -
Effect of host-mimicking medium and biofilm growth on the ability of colistin to kill Pseudomonas aeruginosa.
Microbiology (Reading, England).
2020
Academic Article
GET IT
Times cited: 26 -
Antibiotic interceptors: Creating safe spaces for bacteria.
PLoS pathogens.
2018
Academic Article
GET IT
Times cited: 25